| A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes (NCT01849289) | Novo Nordisk A/S | 2013-06-02 |
| Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus (NCT01892020) | Novo Nordisk A/S | 2013-06-01 |
| A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Bangladesh (NCT01877200) | Novo Nordisk A/S | 2013-06-01 |
| A Trial Investigating the Efficacy and Safety of Flexible vs. Fixed Dosing and Simple vs. Stepwise Titration With Once Daily (OD) Insulin Degludec in Inadequately Treated Subjects With Type 2 Diabetes (NCT01880736) | Novo Nordisk A/S | 2013-06-01 |
| A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Without Other Anti-diabetic Drugs (OADs) (NCT01868542) | Novo Nordisk A/S | 2013-06-01 |
| Use of rFXIII in Treatment of Congenital FXIII Deficiency, a Prospective Multi-centre Observational Study (NCT01862367) | Novo Nordisk A/S | 2013-05-17 |
| An Observational Study to Assess Longitudinal Variation of Immune Biomarkers in Subjects at Risk for Development of Type 1 Diabetes (NCT01846312) | Novo Nordisk A/S | 2013-05-01 |
| Investigation on Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of a Long-acting GLP-1 Analogue (Semaglutide) in an Oral Formulation in Healthy Male Subjects (NCT01866748) | Novo Nordisk A/S | 2013-05-01 |
| A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0287 in Healthy Subjects (NCT01809184) | Novo Nordisk A/S | 2013-03-04 |
| A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily (NCT01814137) | Novo Nordisk A/S | 2013-03-01 |
| A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in Subjects With Type 2 Diabetes (NCT01796366) | Novo Nordisk A/S | 2013-02-21 |
| Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes (NCT01720446) | Novo Nordisk A/S | 2013-02-21 |
| A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin (NCT01713530) | Novo Nordisk A/S | 2013-02-21 |
| A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A (NCT01731600) | Novo Nordisk A/S | 2013-02-20 |
| A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease (NCT01751152) | Novo Nordisk A/S | 2013-02-01 |
| A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years (NCT01789086) | Novo Nordisk A/S | 2013-02-01 |
| Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature (NCT01778023) | Novo Nordisk A/S | 2013-01-17 |
| A Trial Investigating the Effect of Acute Hypoglycaemia on Cognitive Function and Brain Activation Patterns in Subjects With Type 1 Diabetes (NCT01789593) | Novo Nordisk A/S | 2013-01-14 |
| A Trial to Investigate the Impact of Nocturnal Hypoglycaemia on Sleep in Subjects With Type 2 Diabetes (NCT01780272) | Novo Nordisk A/S | 2013-01-01 |
| A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes (NCT01773798) | Novo Nordisk A/S | 2013-01-01 |
| Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A (NCT01692925) | Novo Nordisk A/S | 2012-12-01 |
| A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes (NCT01766245) | Novo Nordisk A/S | 2012-12-01 |
| A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin (NCT01435629) | Novo Nordisk A/S | 2012-11-22 |
| Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes (NCT01541215) | Novo Nordisk A/S | 2012-11-13 |
| A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate (NCT01636843) | Novo Nordisk A/S | 2012-10-30 |
| A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency (NCT01706783) | Novo Nordisk A/S | 2012-10-12 |
| The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification (NCT01664247) | Novo Nordisk A/S | 2012-10-01 |
| A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis (NCT01706159) | Novo Nordisk A/S | 2012-10-01 |
| A Trial Investigating the Safety, Tolerability, and Distribution and Activity in the Body of NNC0148-0000-0287 Injected Under the Skin in Healthy Subjects and in Subjects With Type 1 Diabetes (NCT01730014) | Novo Nordisk A/S | 2012-10-01 |
| A Trial Comparing the Effect of Exercise on Blood Glucose in Subjects With Type 1 Diabetes, Who Are Treated With Either Insulin Degludec or Insulin Glargine (NCT01704417) | Novo Nordisk A/S | 2012-10-01 |
| Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes (NCT01686945) | Novo Nordisk A/S | 2012-09-19 |
| Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A (NCT01493778) | Novo Nordisk A/S | 2012-09-17 |
| Investigation on Safety, Tolerability, and Pharmacokinetics of Single Doses of NNC0113-0987 in Healthy Male Subjects (NCT01690169) | Novo Nordisk A/S | 2012-09-14 |
| An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes (NCT01696266) | Novo Nordisk A/S | 2012-09-05 |
| An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE) (NCT01689025) | Novo Nordisk A/S | 2012-09-01 |
| A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes (NCT01682902) | Novo Nordisk A/S | 2012-09-01 |
| A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy of NNC0114-0006 in Subjects With Active Rheumatoid Arthritis (NCT01647451) | Novo Nordisk A/S | 2012-09-01 |
| The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes (NCT01617434) | Novo Nordisk A/S | 2012-09-01 |
| Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine (NCT01680341) | Novo Nordisk A/S | 2012-08-31 |
| The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy (NCT01618162) | Novo Nordisk A/S | 2012-08-29 |
| The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy (NCT01676116) | Novo Nordisk A/S | 2012-08-29 |
| Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A. (NCT01489111) | Novo Nordisk A/S | 2012-08-03 |
| A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics (NCT01636817) | Novo Nordisk A/S | 2012-08-01 |
| Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations (NCT01680328) | Novo Nordisk A/S | 2012-08-01 |
| A Multi-centre, Open Labelled, Multiple Dosing Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC 0172-2021 Administered Subcutaneously to Healthy Male Subjects and Haemophilia Subjects (NCT01631942) | Novo Nordisk A/S | 2012-06-26 |
| Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment (NCT01620489) | Novo Nordisk A/S | 2012-06-14 |
| A Trial Investigating the Pharmacodynamic Properties of NN1218 in Subjects With Type 1 Diabetes (NCT01618188) | Novo Nordisk A/S | 2012-06-11 |
| Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B (NCT01386528) | Novo Nordisk A/S | 2012-06-07 |
| Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea (NCT01557166) | Novo Nordisk A/S | 2012-06-07 |
| First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid Arthritis (NCT01611688) | Novo Nordisk A/S | 2012-06-04 |
| Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes (NCT01618214) | Novo Nordisk A/S | 2012-06-01 |
| A Trial Investigating the Absolute Bioavailability of Insulin Degludec in Healthy Subjects (NCT01623375) | Novo Nordisk A/S | 2012-06-01 |
| Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjects (NCT01619345) | Novo Nordisk A/S | 2012-06-01 |
| Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin (NCT01519674) | Novo Nordisk A/S | 2012-06-01 |
| Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients (NCT01559103) | Novo Nordisk A/S | 2012-05-31 |
| Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients (NCT01589653) | Novo Nordisk A/S | 2012-05-26 |
| Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B. (NCT01467427) | Novo Nordisk A/S | 2012-05-16 |
| A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0362 in Healthy Subjects (NCT01597713) | Novo Nordisk A/S | 2012-05-01 |
| French Observational Survey to Assess Hypoglycaemia in Insulin-treated Diabetic Patients (NCT01628341) | Novo Nordisk A/S | 2012-05-01 |
| Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773 (NCT01395810) | Novo Nordisk A/S | 2012-04-15 |
| Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects (NCT01572753) | Novo Nordisk A/S | 2012-04-12 |
| Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes (NCT01572740) | Novo Nordisk A/S | 2012-04-05 |
| A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin (NCT01570751) | Novo Nordisk A/S | 2012-04-01 |
| A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 Diabetes (NCT01590836) | Novo Nordisk A/S | 2012-04-01 |
| A Trial Comparing the Efficacy of Insulin Degludec With Insulin Glargine on Glycaemic Control Using Continuous Glucose Monitoring in Patients With Type 1 Diabetes (NCT01569841) | Novo Nordisk A/S | 2012-04-01 |
| Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation (NCT01206101) | Novo Nordisk A/S | 2012-03-21 |
| Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Levels, in Healthy Japanese Subjects (NCT01555749) | Novo Nordisk A/S | 2012-03-12 |
| To Estimate the Percentage of Children and Adolescents in Tunisia With Acceptably Controlled Diabetes Mellitus Type 1 (NCT01493388) | Novo Nordisk A/S | 2012-03-01 |
| Diabetes Attitudes Wishes and Needs (NCT01507116) | Novo Nordisk A/S | 2012-03-01 |
| Safety and Tolerability of NNC0114-0006 at Increasing Dose Levels in Subjects With Rheumatoid Arthritis (NCT01565408) | Novo Nordisk A/S | 2012-03-01 |
| The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes (NCT01536665) | Novo Nordisk A/S | 2012-02-01 |
| Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A (NCT01480180) | Novo Nordisk A/S | 2012-01-30 |
| A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus (NCT01513473) | Novo Nordisk A/S | 2012-01-16 |
| First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy Subjects (NCT01514500) | Novo Nordisk A/S | 2012-01-16 |
| A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes (NCT01513590) | Novo Nordisk A/S | 2012-01-16 |
| Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone (NCT01512108) | Novo Nordisk A/S | 2012-01-10 |
| GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus (NCT01950637) | Novo Nordisk A/S | 2012-01-01 |
| Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries (NCT01503567) | Novo Nordisk A/S | 2012-01-01 |
| An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC) (NCT01511393) | Novo Nordisk A/S | 2012-01-01 |
| A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes (NCT01392573) | Novo Nordisk A/S | 2011-11-28 |
| Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2 (NCT01484262) | Novo Nordisk A/S | 2011-11-14 |
| Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical Practice (NCT01454024) | Novo Nordisk A/S | 2011-11-01 |
| A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 Diabetes (NCT01469143) | Novo Nordisk A/S | 2011-11-01 |
| Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes (NCT01486966) | Novo Nordisk A/S | 2011-11-01 |
| Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects (NCT01473953) | Novo Nordisk A/S | 2011-10-01 |
| A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes (NCT01455142) | Novo Nordisk A/S | 2011-10-01 |
| A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 2 Diabetes (NCT01467414) | Novo Nordisk A/S | 2011-10-01 |
| Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects (NCT01437592) | Novo Nordisk A/S | 2011-09-06 |
| Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin (NCT01388361) | Novo Nordisk A/S | 2011-09-01 |
| Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 Diabetes (NCT01427920) | Novo Nordisk A/S | 2011-09-01 |
| Changing Diabetes in Children (NCT02382757) | Novo Nordisk A/S | 2011-09-01 |
| A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Children With Type 1 Diabetes (NCT01435642) | Novo Nordisk A/S | 2011-09-01 |
| Non-Interventional Study on Safety of Liraglutide in Subjects With Type 2 Diabetes (NCT01345734) | Novo Nordisk A/S | 2011-09-01 |
| Trial Investigating the Safety of NNC 0113-0987 in Healthy Male Subjects (NCT01405261) | Novo Nordisk A/S | 2011-08-01 |
| Observational, Safety Study of NovoNorm® (Repaglinide) and Insulin Analogue Combination Therapy in Type 2 Diabetes in Korea (NCT01355718) | Novo Nordisk A/S | 2011-08-01 |
| Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 Diabetes (NCT01403025) | Novo Nordisk A/S | 2011-07-19 |
| Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers (NCT01401244) | Novo Nordisk A/S | 2011-07-14 |
| Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors (NCT01392547) | Novo Nordisk A/S | 2011-07-01 |
| Survey Evaluating the Psychosocial Effects of Living With Haemophilia (NCT01322620) | Novo Nordisk A/S | 2011-06-03 |
| A Single Dose Trial of NNC 0155-0000-0004 in Patients With Haemophilia A (NCT01365520) | Novo Nordisk A/S | 2011-06-01 |